| (USD) | Mar 2024 | Y/Y change |
|---|---|---|
| Revenue | 1.60M | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, INM returned -36.6% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +36.3% |
| 1 year | -36.6% |
| 5 years | -99.9% |
| 10 years | -99.9% |
| All-time high | $17,754.00 (Mar 2018) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in INM would be worth today ›No. InMed Pharmaceuticals Inc. has not paid a dividend in the past 12 months.
InMed Pharmaceuticals Inc. stock trades on NASDAQ under the ticker symbol INM.
InMed Pharmaceuticals Inc. is part of the Healthcare sector.
InMed Pharmaceuticals Inc. has a market cap of 7.72M USD, based on the latest quote.
InMed Pharmaceuticals Inc. is expected to report earnings around Sep 23, 2026. That date is an estimate and has not been confirmed by the company.
